US Stock MarketDetailed Quotes

MTNB Matinas BioPharma

Watchlist

0.5580
+0.0080+1.45%

Close Mar 4 16:00 ET

0.5580
0.00000.00%

Post 20:01 ET

2.84MMarket Cap-0.12P/E (TTM)

Matinas BioPharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Matinas BioPharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 0.000	--
--	2024/Q4	-- / 0.000	--
--	2024/Q3	0.000 / 0.000	--
Aug 14, 2024	2024/Q2	0.000 / 0.000	--
May 9, 2024	2024/Q1	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 0.000--

--2024/Q4-- / 0.000--

--2024/Q30.000 / 0.000--

Aug 14, 20242024/Q20.000 / 0.000--

May 9, 20242024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

Matinas BioPharma Earnings Reports

Matinas BioPharma | 10-Q: Q3 2024 Earnings Report

Nov 13, 2024 17:23 ET

Matinas BioPharma | 10-Q: Q2 2024 Earnings Report

Aug 14, 2024 16:53 ET

Matinas BioPharma | 8-K: Matinas BioPharma Reports Second Quarter 2024 Financial Results and Provides a Business Update